Skip to content
MarketScale
‹ Back to IndustriesHealthcare

2021 CareChex Awards Released for Top Performing Healthcare Organizations

GREENVILLE, SC – Quantros, a leading provider of quality analytics software to healthcare providers and purchasers, has released their annual CareChex® Awards. These awards celebrate the accomplishments of hospitals and health systems across the nation in specific clinical categories. Quantros has been helping hospitals leverage their data into clear insights and actionable improvements for decades,…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
2021 CareChex Awards Released for Top Performing Healthcare Organizations

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

GREENVILLE, SC – Quantros, a leading provider of quality analytics software to healthcare providers and purchasers, has released their annual CareChex® Awards. These awards celebrate the accomplishments of hospitals and health systems across the nation in specific clinical categories.

Quantros has been helping hospitals leverage their data into clear insights and actionable improvements for decades, allowing patients to feel confident in choosing a hospital differentiated with a CareChex® award.

2021 CareChex® awards use CMS data from October 2016 to September of 2019 and are based on Quantros’ proprietary scoring system which compares inpatient performance across general, acute, non-federal US hospitals.

Quantros prides itself in providing the most comprehensive and objective calculation of hospital and health system quality performance in the industry:

  • Our vast datasets allow for accurate benchmarking and risk-adjustment
  • No self-reported or survey data is included
  • CareChex® awards are not “pay-to-play,” all general, acute, non-federal hospitals within the US are included
  • Results are tested for statistical significance, resulting in clearer, more accurate performance differentiation across 39 clinical categories in both Medical Excellence and Patient Safety.

Why is CareChex® by Quantros superior to other quality rating methods?

CareChex Awards by Quantros utilizes a peer-reviewed risk-adjustment methodology to more reliably measure rates of mortality, complications and readmissions — appropriately weighting and accounting for all of the risk factors relating to a patient’s principal and secondary diagnosis, as well as other patient characteristics that may increase the probability for adverse clinical outcomes. These rankings do not include any self-reported data.

If you are interested in if your organization earned awards, click here to request your 2021 award summary.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

CMS Sets $90-$420 Per-Patient Payments for Chronic Care Tech

CMS Sets $90-$420 Per-Patient Payments for Chronic Care Tech

CMS's ACCESS payment model, fully active as of July 2026, pays companies $90 to $420 per Medicare beneficiary per year for technology-supported chronic care tied to outcomes, according to HFMA. The model also requires participants to connect through CMS-designated interoperability networks, and more tech companies than traditional providers have signed on so far.

  • 01CMS ACCESS model provides annual payments of $90 to $420 per Medicare beneficiary for chronic care supported by technology.
  • 02Payments in the ACCESS model range from $90 to $420 per beneficiary per year depending on whether specified outcome targets are met.
  • 03The initiative aims to promote the integration of technology in chronic care management.

Sep 10, 2026

Google’s AlphaGenome Atlas puts billions of DNA variants in reach

Google’s AlphaGenome Atlas puts billions of DNA variants in reach

AlphaGenome Atlas gives researchers predicted molecular effects for possible DNA changes across the human genome, helping teams prioritize variants for experimental follow-up.

  • 01The Atlas covers roughly nine billion possible single-letter DNA substitutions, according to The Verge.
  • 02Predictions can prioritize research questions but do not establish clinical findings.
  • 03The useful implementation pattern is prediction, study-specific evidence, then validation.

Sep 9, 2026

OpenAI put 10,000 AI agents on Navier–Stokes. Healthcare R&D should pay attention

OpenAI put 10,000 AI agents on Navier–Stokes. Healthcare R&D should pay attention

OpenAI says roughly 10,000 AI agents produced a proposed Navier–Stokes solution in 88 hours, followed by Lean verification. For healthcare and life sciences, the immediate signal is a research workflow built around parallel agents, code execution, provenance and formal checking—not a ready-made clinical simulator.

  • 01OpenAI's result is a proposed proof under review, not a new clinical simulation product.
  • 02The near-term B2B signal is a coordinated research stack combining agents, code and formal verification.
  • 03Healthcare buyers should evaluate provenance, reproducibility, security and cost per validated result.

Sep 9, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512